View Study [4]"Safety and efficacy of subcutaneous Melanotan-II for tanning purposes" Ugwu SO, Blanchard J, Dorr RT, et al., 1997 Finding: Clinical testing showed MT-2 was well-tolerated at doses up to 0.03 mg/kg with predictable side effects (flushing, nausea)
A substance falls under S2 because of what it does to the growth hormone axis, not simply because it lacks a marketing authorisation
Even intravenous administration of GLP-1 at a physiological postprandial dose of 0.3 pmol/kg/min significantly slowed the rate of gastric emptying in healthy subjects, bringing them into a state of gastroparesis (Little et al., 2006)
role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
Regular monitoring becomes crucial during this transition period, and your healthcare team should provide guidance on adjusting other medications or implementing lifestyle modifications to maintain glycaemic control
Recommendation: Take as directed by your healthcare practitioner